A Rollover Study for Patients Who Received CP-675,206 in Other Protocols, to Allow the Patients Access to CP-675,206 Until This Agent Becomes Commercially Available or Development is Discontinued.



Status:Active, not recruiting
Conditions:Prostate Cancer, Colorectal Cancer, Skin Cancer, Cancer
Therapuetic Areas:Oncology
Healthy:No
Age Range:Any
Updated:3/7/2019
Start Date:March 5, 2007
End Date:February 28, 2020

Use our guide to learn which trials are right for you!

A Rollover Protocol For Patients Who Received CP-675,206 In Other Protocols

This study is intended to provide access to CP-675,206 for patients who have previously
received CP-675,206 in a clinical trial.


Inclusion Criteria:

- The subject must have already received CP-675,206 in another protocol

- Females of childbearing potential must agree to practice a form of effective
contraception for 12 months following any dose of study drug. The definition of
effective contraception will be based on the judgement of the investigator.

- Subject must be willing and able to provide written informed consent and to comply
with scheduled visits and other trial procedures

Exclusion Criteria:
We found this trial at
10
sites
?
mi
from
Los Angeles, CA
Click here to add this to my saved trials
?
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
?
mi
from
Aurora, CO
Click here to add this to my saved trials
?
mi
from
Houston, TX
Click here to add this to my saved trials
?
mi
from
Indianapolis, IN
Click here to add this to my saved trials
?
mi
from
Little Rock, AR
Click here to add this to my saved trials
?
mi
from
Madison, WI
Click here to add this to my saved trials
?
mi
from
Meldola, FC,
Click here to add this to my saved trials
?
mi
from
New York, NY
Click here to add this to my saved trials
?
mi
from
Tampa, FL
Click here to add this to my saved trials